Content Type: Research Publications

The Impact of Electronic Health Record Discontinuity on Prediction Modeling

March 6, 2026

Physician Experiences with and Perceptions of Risk Evaluation and Mitigation Strategy Programs with Elements to Assure Safe Use

March 6, 2026

Association of Advisory Committee Votes with US Food and Drug Administration Decision-Making on Prescription Drugs, 2010-2021

March 6, 2026

Patenting Strategies on Inhaler Delivery Devices

March 6, 2026

Five-Year Sales for Newly Marketed Prescription Drugs with and Without Initial Orphan Drug Act Designation

March 6, 2026

Inflationary Rebates for Generic Drugs Sold Through Medicaid Saved Billions During 2017-20

March 6, 2026

Health Technology Assessment for Cancer Medicines Across the G7 Countries and Oceania: An International, Cross-Sectional Study

March 6, 2026

An Empirical Review of Key Glucose Monitoring Devices: Product Iterations and Patent Protection

March 6, 2026

The Prevalence of Drug Patent Term Extensions in the United States, 2000-2018

March 6, 2026

Medicaid Spending on Antiretrovirals From 2007 Through 2019

March 6, 2026

Analysis of Risk Evaluation and Mitigation Strategies for Teratogenic Drugs: Variation in Primary and Secondary Prevention Measures

March 6, 2026

The $5 Billion Hop: Glatiramer Acetate and the US Patent System

March 6, 2026